Navigation Links
ChromaDex Awarded Nutrition Business Journal Scientific Achievement
Date:1/26/2009

Forward-thinking stevia standards snag company award

IRVINE, Calif., Jan. 26 /PRNewswire-FirstCall/ -- ChromaDex Corporation, (OTC Bulletin Board: CDXC) a leader in phytochemical reference standards and contract research, announced today that Nutrition Business Journal, a leading nutrition, natural products and alternative health care magazine, selected the Company as one of the 2008 NBJ Scientific Achievement Award recipients for its achievement in setting stevia standards as part of its work with Cargill.

"The broad commercial application of stevia has long been anticipated, and our work with Cargill has set the standard for safety and quality," said Frank Jaksch, CEO and co-founder of ChromaDex. "We have worked hard to be the leader in reference standards and we appreciate the validation of our work by Nutrition Business Journal."

As part of its partnership with Cargill, Chromadex will supply global analytical reference standards and research materials for the individual sweet components of stevia, a natural product originating from the leaves of the stevia plant. With no previously accepted standards, this is the first time food and beverage companies can validate quality of stevia for use in consumer products.

NBJ Business Achievement Awards are awarded annually to companies that have demonstrated achievement in categories such as Management Achievement, Investment in the Future, Education, Environment & Sustainability, Organic Excellence and Wall Street Award for Stock Performance. Award winners will be honored at a dinner in July at the NBJ Summit, to be held at the St. Regis Monarch Beach Resort in Dana Point, California.

About ChromaDex

ChromaDex is a leader in the development of Phytochemical and Botanical Reference Standards and the creation of associated intellectual property. ChromaDex is committed to sustainable "Green chemistry" and provides the dietary supplement, food, beverage, nutraceutical and cosmetic industries with the analytical tools and services to meet product regulatory, quality, efficacy and safety standards.

Forward-Looking Statements

Any statements that are not historical facts contained in this release are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to: the ability to market, produce and sell the referenced ingredients; risks relating to product and customer demand, market acceptance of our products; the effect of economic conditions both nationally and internationally; the ability to protect our intellectual property rights; the impact of any litigation or infringement actions brought against us; competition from other providers and products; risks in product development; our ability to raise capital to fund continuing operations; the ability to complete transactions; and other factors discussed from time to time in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law.

www.chromadex.com


'/>"/>
SOURCE ChromaDex Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ChromaDex Partners With Cargill to Provide Global Quality Control Methods and Standards for Sweet Components of Stevia
2. ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds
3. SeQual Technologies is Awarded the U.S. Army Airworthiness Certification
4. USC awarded $22.2M NIH national biomedical informatics infrastructure coordinating center contract
5. VTS Medical Systems, LLC Awarded Frost & Sullivan Excellence in Healthcare, Product Line Strategy Leadership Award for 2009
6. Boston Scientific Awarded CRM Contract by Department of Veterans Affairs
7. Aribex(R) Awarded Patents for Handheld X-ray
8. Access Family Services and Compass Adult Care Awarded Three Year Accreditation from CARF!
9. Custody Awarded to Stepfather: 10 Month Old Child Now to Have Open-Heart Surgery
10. Companion Global Healthcare Awarded for Outstanding Web Site
11. AMERIGROUP Community Care of Ohio Awarded New Health Plan Accreditation From NCQA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, ... dedicated to helping service members that have been wounded in battle and their families. ...
(Date:6/24/2016)... ... 2016 , ... Finally, a bruise cream that really works. Originally designed ... into the post-surgical treatment plans of a variety of other procedures including, but not ... effective for bruising and causes a rapid resolution of bruising and inflammatory changes compared ...
(Date:6/24/2016)... ... 24, 2016 , ... Today, InhaleLabs.com (Inhale) offilially launched its site, ... matching users with high quality water pipes within an ideal price range. The site ... was founded by two brothers, Nick and Mike Hunter, who use medical cannabis to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Terumo BCT, ... organization responsible for clinical transfusion research programs and for the blood supply in ... Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , Currently in its ...
(Date:6/23/2016)... ... June 23, 2016 , ... The Mechille Wilson Agency, ... throughout Jasper County and the surrounding region, is initiating a charity drive to assist ... raise funds earmarked for a scholarship fund that will be presented to the chosen ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: